Stimulation of sensitized mast cells by antigen leads to the activation of signal transduction pathways including signals generated through the mobilization of calcium and PKC 1 (1) (2) (3) . One of the responses to these signals is the fusion of secretory granules with the plasma membrane, allowing release of preformed mediators such as histamine and serotonin from the cell. Calcium and PKC are necessary and sufficient for secretion in permeabilized cells (4) . Fusion of the secretory granules with the plasma membrane is accompanied by cytoskeletal rearrangements, which may facilitate fusion by removing a barrier of actomyosin which physically separates the two entities. Previous work has demonstrated that activation of the rat mast cell line RBL-2H3 with antigen or with calcium ionophore leads to the rapid PKC-dependent serine phosphorylation of nonmuscle myosin on both light chains and heavy chains (5) . The phosphorylation of nonmuscle myosin heavy chain (NMHC)-II, which occurs close to the carboxyl terminus at the end of the coiled-coil region, has been proposed to contribute to rearrangement of the actomyosin cytoskeleton and thus facilitate secretory granule fusion at the plasma membrane and resultant mediator release (5) .
Recent studies in a variety of cell lines have demonstrated that NMHC-II can also be threonine phosphorylated in response to stimuli. In rat PC12 cells, NMHC-II phosphorylation in response to bradykinin was shown to be calcium-dependent, and was regulated by activity of the small GTPase Rac. NMHC-II phosphorylation was accompanied by loss of cortical myosin (6) . Calcium-dependent phosphorylation of NMHC-II was also shown in response to nutrient stimulation in the rat insulinoma cell line RINm5F, and was proposed to play a role in insulin secretion (7) . However, in neither study was the site of threonine phosphorylation of the myosin heavy chain determined. In light of these findings, it was of interest to determine whether threonine phosphorylation of NMHC-II also occurs in mast cells. Here we demonstrate that stimulation of RBL-2H3 m1 cells, an RBL-2H3 cell line made to express the muscarinic m1 receptor (8) , with antigen or carbachol leads to calcium-dependent threonine phosphorylation of NMHC-IIA. We provide evidence that Thr-1940 , situated distal to the coiled-coil region within a CaM kinase consensus sequence, is the residue phosphorylated. We also demonstrate that CaM kinase II is activated by antigen and carbachol with time courses similar to those obtained for NMHC-IIA threonine phoshorylation. Finally, a specific inhibitor of CaM kinase attenuates threonine phosphorylation of NMHC-IIA, and also inhibits secretion in response to carbachol.
MATERIALS AND METHODS
RBL-2H3 m1 cells and Y79 cells were generously provided by Drs. Michael Beaven and Sachiyo Kawamoto (NHLBI), respectively, and were cultured in DMEM supplemented with 10% fetal bovine serum and penicillin/streptomycin. PMA, GF109203X, BAPTA-AM, dimethylsphingosine, autocamtide-2, KN-92, and KN-93 were obtained from Calbiochem (San Diego CA). Carbachol, BSA-DNP conjugate and phosphoamino acids were obtained from Sigma. Mouse anti-dinitrophenol IgE was obtained from M. Beaven or from Sigma. Anti-phosphothreonine antibody (rabbit polyclonal) was obtained from Zymed Laboratories Inc. (South San Francisco CA). Anti-phospho-ERK and protein A/G-agarose were from Santa Cruz Biotech (Santa Cruz CA). Chymotrypsin-TLCK was from Worthington Biochemicals (Lakewood, NJ).
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CaM kinase II was from New England Biolabs (Beverly, MA). Rabbit polyclonal antibodies to platelet myosin, which recognizes epitopes primarily in the rod region of NMHC-IIA, and to the carboxyl terminus of human NMHC-IIA (anti-HA), have been described (9) . A rabbit polyclonal antibody raised against 13 amino acid residues at the amino terminus of human NMHC-IIA was kindly provided by Dr. Mary Anne Conti (NHLBI). Anti-GFP was obtained from CLONTECH (Palo Alto, CA). 4 -20% SDS-polyacrylamide gels were obtained from FMC (Rockland, ME), while 4 -12% NuPAGE gels were obtained from Novex (San Diego, CA). A synthetic peptide corresponding to amino acids 1933-1951 of rat NMHC-IIA was obtained from Research Genetics (Huntsville, AL).
Antigen Stimulation of Mast Cells-RBL-2H3 cells were incubated overnight with anti-dinitrophenol IgE (0.5 g/ml), washed with phosphate-buffered saline, and the medium replaced with DMEM containing 0.1% BSA. Cells were then stimulated with DNP-BSA (20 ng/ml), washed twice with ice-cold phosphate-buffered saline containing 5 mM EDTA and 1 mM sodium vanadate, lysis buffer added, and the cells scraped from the plate with a plastic scraper. Lysis buffer consisted of 25 mM Hepes, pH 7.5, 0.3 M NaCl, 1.5 mM MgCl 2 , 0.1% Triton X-100, 1 mM sodium orthovanadate, 20 mM ␤-glycerophosphate, 0.2 mM EDTA, 0.5 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 20 M leupeptin, 0.15 units/ml aprotinin at 4°C. Cell lysates were transferred to a microcentrifuge tube, and Triton-insoluble material pelleted at 14,000 ϫ g for 10 min. After taking an aliquot for protein determination (10) to permit equal protein loading of gel lanes, samples were heated in sample buffer and subjected to SDS-PAGE. Samples were transferred to polyvinylidene difluoride membranes (Immobilon-P, Millipore) and subjected to immunoblotting using standard methods. Bound secondary antibody was detected using luminol blotting reagents (Santa Cruz Biotech), and the signal captured on Biomax MR film (Kodak). Films were scanned using a laser densitometer (Molecular Dynamics) and bands quantified using ImageQuant software.
Immunoprecipitation-Cleared cell lysates prepared as above were rocked at 4°C with the appropriate antibody for 1 h. Protein A/Gagarose was then added, and rocking continued for a further 2 h. The protein A/G-agarose beads were washed 4 times with ice-cold phosphate-buffered saline, and then incubated with sample buffer at 75°C for 10 min to remove bound protein from the beads. The supernatant was subjected to SDS-PAGE and immunoblotting as described above.
Proteolytic Localization of the Threonine Phosphorylation Site-For chymotryptic digestion, cell lysate (2 mg/ml) was incubated with TLCKtreated chymotrypsin, 20 g/ml at 25°C. Aliquots were taken at time points, heated with sample buffer, and subjected to SDS-PAGE and immunoblotting. For hydroxylamine cleavage, cell lysate was diluted 1:10 with 2 M hydroxylamine hydrochloride, 6 M guanidine hydrochloride which had been adjusted to pH 9.0 with LiOH. The mixture was incubated at 45°C for 3 h, dialyzed against 6 M urea, 40 mM Hepes, pH 7.5, and concentrated by centrifugation in a Microcon 10 centrifugal filter (Millipore). An aliquot of the concentrated digested lysate was then subjected to SDS-PAGE and immunoblotting.
Fusion Protein Expression and Mutation-A 1906-base pair fragment (including 3Ј-untranslated residues), obtained from a clone of mouse NMHC-IIA provided by M. Conti, was subcloned into pGEX-5T2 to give a glutathione S-transferase fusion protein including the carboxyl-terminal 199 amino acids of NMHC-IIA. The threonine residue located 22 amino acids from the carboxyl terminus, corresponding to rat NMHC-IIA Thr-1940, was mutated to Ala using the Quikchange system (Stratagene, La Jolla, CA). The primers used were 5Ј-TGTTCGGAAAG-GCGCCGGCGACTGCTCAG-3Ј and the complementary antisense primer; the mutated residue, shown in bold, converts Thr to Ala and introduces an SfoI site for rapid clone selection. A 450-base pair fragment was subcloned from a clone encoding human NMHC-IIA (Dr. Qize Wei, NHLBI) into pGEX-4T1 to give a glutathione S-transferase fusion protein encoding the carboxyl-terminal 150 amino acids of NMHC-IIA. Ala-1940 was mutated to Thr using the primers 5Ј-CCGGAAAGGCAC-CGGGATGGCTCC-3Ј and the complementary antisense primer; the mutated residue, shown in bold, converts Ala to Thr and removes an SfoI site. SDS-PAGE-purified primers were obtained from Life Technologies, Inc. (Gaithersburg MD). Fusion proteins were expressed in Escherichia coli and purified by standard methods (11) .
Mammalian Expression Experiments-Mammalian expression vector encoding constitutively active CaM kinases I, II, and IV (12) were generously provided by Dr. Richard Maurer (Oregon Health Sciences University). An expression vector encoding human NMHC-IIA with GFP fused to the amino terminus was kindly provided by Q. Wei. Ala-1940 was mutated to Thr as described above for the human pGEX-4T1 construct. Transfection was performed using Effectene (Qiagen, Valencia, CA) following the manufacturer's standard protocol. pAdVantage (Promega, Madison, WI) was co-transfected with the expression vectors to improve expression levels by inhibiting dsRNA-activated inhibitor.
In Vitro Phosphorylation with CaM Kinase II and CaM Kinase Assay-Protein or peptide substrates were incubated with CaM kinase II, and where indicated [␥-32 P]ATP, 250 Ci/mmol, in a reaction buffer consisting of 20 mM Tris, pH 7.5, 10 mM MgCl 2 , 2 mM CaCl 2 , 2.4 mM calmodulin, 0.5 mM dithiothreitol, 0.1 mM EDTA, 50 M ATP. Phosphorylated proteins and peptides were then separated on NuPAGE 4 -12% gels run in MES buffer. CaM kinase II activity in cell lysates was determined by phosphorylation of autocamtide-2 and capture of the phosphorylated peptide on Whatman P81 phosphocellulose as described previously (13) .
Phosphoamino Acid Determination-After in vitro labeling of peptide, the reaction mixture was lyophilized and taken up in 6 M HCl, 50 l. The mixture was incubated at 110°C for 1 h, and lyophilized after addition of 400 l of water. The mixture was dissolved in electrophoresis buffer (glacial acetic acid/pyridine/water, 10:1:189, pH 3.5) (14), marker phosphoamino acids added, and an aliquot spotted on to a 20 ϫ 20-cm glass-backed cellulose TLC plate. Electrophoresis was carried out for 30 min at 1.3 kV, the plate dried, and the phosphoamino acids visualized with ninhydrin. The plate was then subjected to autoradiography.
Measurement of Secretion by Hexosaminidase Assay-The release of the secretory granule marker hexosaminidase was measured as described previously (15) . Released hexosaminidase was expressed as a percentage of total hexosaminidase.
Statistical Analysis-Results are presented as mean Ϯ S.E. Comparisons between 2 groups were performed by paired or unpaired Student's t test as appropriate. Comparisons between more than 2 groups were made by repeated measure analysis of variance followed by post-hoc Tukey HSD test to assess significance of differences between individual groups.
RESULTS

Stimulation of RBL-2H3 Cells Results in Threonine Phosphorylation of NMHC II-A-RBL-2H3
m1 cells, sensitized by overnight incubation with anti-DNP IgE, were stimulated with DNP-BSA, and threonine phosphorylation of lysate proteins detected by immunoblotting using a specific antibody to phosphothreonine. Fig. 1A shows that DNP-BSA caused the rapid appearance of phosphothreonine in a band of 220 kDa, with maximal threonine phosphorylation at 10 -15 min. To determine the specificity of the response to antigen stimulation, cells were stimulated with carbachol, which acts via the stably transfected m1 muscarinic receptors. Carbachol also caused threonine phosphorylation of the 220-kDa band (Fig. 1B) , but in this case the response was more rapid, detectable within 15 s and maximal at 2 min. The responses thus parallel the calcium responses to the agents, which are more rapid for carbachol than for antigen (16) . A comparison of the time courses for the 2 agents is shown in Fig. 1C . The maximal threonine phosphorylation was also greater for carbachol; the mean response to antigen was 59 Ϯ 8% of that to carbachol (n ϭ 3; p Ͻ 0.01).
To confirm the identity of the 220-kDa band, NMHC-IIA was immunoprecipitated from RBL-2H3 lysates using anti-HA antibody which recognizes the carboxyl terminus of NMHC-IIA, and the immunoprecipitates immunoblotted with anti-PT antibody. Fig. 2 (left) shows that the antibody recognized a 220-kDa band in the anti-HA immunocomplexes from carbacholtreated cells, while in untreated control cells the 220-kDa band was barely detectable. Omitting anti-HA from the immunoprecipitation resulted in loss of the phosphothreonine band, indicating specificity of the immunoprecipitation. Conversely, NMHC-IIA was increased in anti-PT immunocomplexes obtained from carbachol-treated but not control cells (Fig. 2,  right) . Since RBL-2H3 cells contain only NMHC-IIA and are devoid of the NMHC-IIB isoform (17) , the NMHC phosphorylated in these experiments can be identified unequivocally as NMHC-IIA.
Threonine Phosphorylation of NMHC Is Calcium-depend-ent-Threonine phosphorylation of NMHC in RINmF5 and PC12 cells is calcium-dependent (6, 7). RBL-2H3 cell degranulation in response to antigen requires an increase in intracellular calcium, and is also dependent on influx of extracellular calcium. To assess the role of calcium in the threonine phosphorylation of NMHC in RBL-2H3 cells, the cells were incubated with the calcium ionophore ionomycin. Antigen-activated threonine phosphorylation of NMHC-IIA was mimicked by the calcium ionophore ionomycin (Fig. 3A) , demonstrating that influx of extracellular calcium is sufficient to cause threonine phosphorylation of NMHC-IIA. Responses to both antigen stimulation and ionomycin were inhibited by preloading cells with the calcium chelator BAPTA, indicating that a rise in intracellular calcium is necessary for stimulation of threonine phosphorylation. Incubation of cells with EGTA to chelate extracellular calcium and prevent calcium influx also inhibited threonine phosphorylation of NMHC in response to antigen and ionomycin (Fig. 3A) , demonstrating that influx of extracellular calcium is also required. Since the incubation time with EGTA was brief (2 min), depletion of intracellular calcium stores is an unlikely explanation for the inhibitory effects of this chelator. Antigen-mediated mobilization of calcium in RBL-2H3 cells has been reported to be mediated primarily by the action of sphingosine kinase to yield sphingosine 1-phosphate, which releases calcium from intracellular stores leading in turn to the uptake of extracellular calcium (16) . To assess the involvement of sphingosine kinase in the threonine phosphorylation of NMHC, cells were incubated with the specific sphingosine kinase inhibitor dimethylsphingosine (DMS) (18) . Threonine phosphorylation of NMHC in response to antigen was completely abrogated by DMS, indicating that production of sphingosine 1-phosphate is a necessary step in the activation of the threonine kinase (Fig. 3B) . In contrast, DMS had no effect on the response to carbachol, consistent with the primary route of calcium mobilization being via the PLC-mediated production of inositol 1,4,5-trisphosphate (16) . DMS also had no effect on ionomycin-mediated NMHC threonine phosphorylation, consistent with the action of DMS being upstream of ionomycin at the level of blocking calcium release.
Threonine Phosphorylation of NMHC Involves CaM Kinase and Not PKC-PKC is activated in antigen-stimulated RBL-2H3 cells, resulting in phosphorylation of NMHC at a serine residue in the carboxyl terminus (5). PKC was not involved in threonine phosphorylation of NMHC, however, as treatment of RBL-2H3 cells with the phorbol ester PMA had no effect on threonine phosphorylation of NMHC (Fig. 4A, top) . However, it did increase levels of phosphorylated ERK (Fig. 4A, bottom) , indicating that PKC was activated. The PKC independence of NMHC-IIA threonine phosphorylation was confirmed by pretreating IgE-sensitized cells with the specific PKC inhibitor GF109203X; the inhibitor had no effect on subsequent threonine phosphorylation of NMHC-IIA in response to antigen. However, GF109203X did inhibit the increases in pERK in response to both antigen and PMA (Fig. 4A) .
The other major class of calcium-activated serine/threonine kinases is the calcium/calmodulin-dependent protein kinases. To test the role of CaM kinase in phosphorylation of NMHC-IIA, cells were preincubated with the CaM kinase inhibitor KN-93, and with the inactive analog KN-92. KN-93, which has no effect on myosin light chain kinase or PKC activity (19) , caused significant inhibition of NMHC-IIA phosphothreonine responses to carbachol (Fig. 4B) and antigen (Fig. 4C) .
However, the inactive homolog KN-92 was without effect, suggesting that the inhibition in response to KN-93 is a specific effect.
Ionomycin Causes Threonine Phosphorylation of NMHC in Rodent but Not Human Cells-Ionomycin has previously been shown to stimulate threonine phosphorylation of NMHC in PC12, N1E-115, and RINm5F cells (6, 7) , which are all derived from rodent sources. Treatment of mouse embryonic fibroblasts also resulted in threonine phosphorylation of NMHC (Fig. 5) . Similar results were obtained both in wild type cells and in cells obtained from embryos in which NMHC-IIB had been ablated (20) , consistent with NMHC-IIA being the isoform phosphorylated (results not shown). However, stimulation of human-derived HeLa cells with ionomycin did not lead to detectable threonine phosphorylation of NMHC (Fig. 5, upper  panel) , despite the presence of NMHC-IIA in these cells (Fig. 5,  lower panel) . Similarly Y79 cells, a human retinoblastoma cell line, did not respond to ionomycin by threonine phosphorylation (results not shown).
The Phosphorylated Threonine Is Close to the Carboxyl Terminus of NMHC-IIA-Hydroxylamine cleaves specifically between asparagine and glycine residues, and thus cleaves rat NMHC-IIA into only 6 fragments. Arranged from the amino terminus to the carboxyl terminus, the sizes are 4.4, 2.4, 21, 7, 44, and 147 kDa. Immunoblotting of hydroxylamine-digested antigen-stimulated RBL-2H3 lysate showed phosphothreonine in 2 bands, at approximately 150 and 190 kDa (Fig. 6) . The 150-kDa band is consistent with the carboxyl-terminal 147-kDa fragment (amino acids 696 -1961), while the 190-kDa band is consistent with incomplete cleavage of the 147-kDa fragment and the adjacent 44-kDa fragment (amino acids 306 -695). To confirm this, the immunoblot was stripped and reprobed with anti-HA; the antibody recognized the 150-and 190-kDa bands, showing that they both contain the carboxyl terminus of NMHC-IIA. No other phosphothreonine bands were detected apart from the band at 35 kDa, which is found in untreated lysates and is apparently resistant to hydroxylamine treatment.
Treatment of antigen-activated RBL-2H3 cell lysate with TLCK-chymotrypsin led to the rapid disappearance of phosphothreonine from NMHC without the appearance of any major bands at lower molecular weight (results not shown). The disappearance of phosphothreonine paralleled the disappearance of signal obtained after stripping the blot and reprobing with anti-HA, a rabbit polyclonal antibody raised against the 12 amino acids at the extreme carboxyl terminus of the human NMHC-IIA. However, no significant loss of myosin was detected with anti-platelet myosin antibody, which recognizes epitopes throughout myosin but primarily in the rod region. These results suggested that the disappearance of phospho- threonine was the result of clipping of a small peptide from the carboxyl terminus of NMHC-IIA, so that the phosphothreonine was removed without significantly affecting the migration of the remaining myosin molecule. It has previously been shown that the carboxyl terminus of NMHC distal to the coiled-coil region is clipped rapidly by chymotrypsin; phosphoserine phosphorylated by casein kinase II disappears rapidly when NMHC is treated with chymotrypsin, while the nearby phosphoserine in the coiled-coil region labeled by PKC is much more resistant to chymotrypsin proteolysis (21) .
CaM Kinase II Phosphorylates the Carboxyl Terminus of Mouse NMHC-IIA in Vitro-To explore further the difference between rodent and human NMHC-IIA in susceptibility to threonine phosphorylation, glutathione S-transferase fusion proteins containing the carboxyl termini of mouse and human NMHC-IIA were expressed in E. coli. Rat (17) and mouse 2 NMHC-IIA contain a threonine residue (Thr-1940) between the coiled-coil region and the carboxyl terminus, which is part of a CaM kinase consensus sequence. In the human NMHC-IIA sequence this threonine is replaced by alanine (22) . Incubation of the mouse fusion protein with CaM kinase II and ATP resulted in phosphorylation of the fusion protein (Fig. 7A) . In contrast, a fusion protein containing the carboxyl terminus of human NMHC-IIA was not phosphorylated by CaM kinase II. Immunoblotting confirmed the presence of phosphothreonine in the mouse but not the human fusion protein (results not shown). Mutation of Thr-1940 to alanine in the mouse fusion protein prevented phosphorylation by CaM kinase II (Fig. 7B) , while the reciprocal mutation converting Ala to Thr in the human fusion protein led to phosphorylation by CaM kinase II (Fig. 7C) .
To confirm that Thr-1940 is phosphorylated in vitro by CaM kinase II, a peptide corresponding to residues 1933-1951 of rat NMHC-IIA (RRIVRKGTGDCSDEEVDGK) was phosphorylated by CaM kinase II. The peptide was readily phosphorylated (Fig. 7D) , and phosphoamino acid analysis of the phosphorylated peptide confirmed that the phosphate was incorporated only into Thr-1940 (Fig. 7E) .
Constitutively Active CaM Kinases II and IV Phosphorylate Thr-1940 in Situ-To determine whether CaM kinases can phosphorylate NMHC-IIA in situ, HeLa cells were transfected with plasmids encoding constitutively active CaM kinases I, II, or IV. Cells were also co-transfected with a plasmid encoding mutant human NMHC-IIA with Ala-1940 converted to Thr, and with GFP fused to the amino terminus. Threonine phosphorylation of cell proteins was analyzed 48 h later by immunoblotting. Ala 3 Thr-1940 human NMHC-IIA was threonine phosphorylated in situ by activated CaM kinases II (Fig. 8A,  lane 3 
) or IV (lane 4), but not CaM kinase I (lane 2).
Co-transfection of wild-type and Ala 3 Thr-1940 NMHC-IIA with CaM kinase II showed that only the mutant protein was threonine phosphorylated (Fig. 8B, lane 3) . Endogenous NMHC-IIA was also not phosphorylated by transfected CaM kinase II (lanes 1 and 2) . Measurement of CaM kinase II activity in the lysates showed that the activity was similar in all cases, increased approximately 10-fold over basal levels, excluding differences in CaM kinase transfection efficiency as a factor. Similar results were obtained when CaM kinase IV was co-transfected in place of CaM kinase II (results not shown).
CaM 2H3 cells in response to stimuli which cause NMHC phosphorylation, CaM kinase II activity was determined in cell lysates following cell stimulation (Fig. 9) . Carbachol stimulation of RBL-2H3 m1 cells led to a rapid increase in autonomous calcium/calmodulinindependent CaM kinase activity which was detectable within 15 s, peaked at 2 min, and returned toward baseline by 30 min. Stimulation of IgE-sensitized cells with DNP-BSA led to a slower increase in activity which was maximal at 10-20 min. The increases in CaM kinase II activity thus parallel the increase in NMHC-IIA threonine phosphorylation.
Inhibitors of CaM Kinase Inhibit Secretion-To determine whether CaM kinase has any functional role in the secretory process in RBL-2H3 cells, cells were stimulated with antigen or with carbachol in the presence or absence of inhibitors of CaM kinases, and secretion monitored by the release of hexosaminidase. KN-93, inhibited hexosaminidase release in response to carbachol, while KN-92, an inactive analogue of KN-93, had no effect on secretion (Fig. 10A) . In contrast, KN-93 had only a small inhibitory effect on secretion in response to antigen (Fig.  10B) . Moreover, there was no significant difference between the inhibitory effects of the active and inactive homologs, suggesting that this may represent a nonspecific effect.
DISCUSSION
The activation of secretory cells and release of mediators from secretory granules requires the granules to penetrate a cortical cytoskeletal barrier of actomyosin and other components in order to fuse with the plasma membrane and release their contents into the extracellular space (23) . Previous work has shown that stimulation of sensitized mast cells with antigen leads to the rapid PKC-dependent phosphorylation of nonmuscle myosin on serine residues in both the light and heavy chains (5) . The kinetics of early shape change and formation of myosin-deficient lamellopodia in RBL-2H3 cells correlate temporally, consistent with a role for myosin phosphorylation in the disruption of the cortical actomyosin rim that occurs during mast cell activation (24). This disruption may in turn facilitate interaction between the secretory granule and the plasma membrane. Here we demonstrate for the first time that CaM kinase II is activated in RBL-2H3 cells by stimuli which increase cytoplasmic calcium. The activation of CaM kinase II results in the phosphorylation of NMHC-IIA at Thr-1940, close to the carboxyl terminus and distal to the coiled-coil region.
The essential role of increases in intracellular calcium and PKC activity in mast cell activation have been recognized for many years (1-4) . However, the potential role of the other main calcium-dependent kinase family, the CaM kinases, in mast cell activation has not been studied in depth. The CaM kinases are a family of three kinases, CaM kinases I, II, and IV. CaM kinases I and IV are monomeric, while CaM kinase II is a large multimer. CaM kinase I and IV, but not CaM kinase II, are regulated by an upstream kinase, CaM kinase kinase (25) . CaM kinase II is activated in RBL-2H3 m1 cells stimulated with antigen or with carbachol, and activation of CaM kinase II is accompanied by the threonine phosphorylation of NMHC-IIA with a similar time course. The phosphorylation is calcium-dependent, requiring both an elevation of intracellular calcium, blocked by BAPTA, and influx of extracellular calcium, blocked by brief incubation with EGTA. Carbachol stimulation led to a larger increase in NMHC-IIA phosphothreonine than antigen, paralleling the larger increase in intracellular calcium (16) and the greater extent of secretion (8) found with carbachol relative to antigen. Phosphorylation appears to be mediated via a CaM kinase-dependent pathway rather than by PKC, since threonine phosphorylation of NMHC is inhibited by the CaM kinase inhibitor KN-93 but not by the PKC inhibitor GF109203X. In addition, treatment of the cells with PMA did not result in threonine phosphorylation of NMHC-IIA. KN-93 inhibits CaM kinase II with an IC 50 of 0.37 M (19), but also inhibits CaM kinase I and IV (IC 50 2.7 and 50 M, respectively) (26) . While the time course of activation of CaM kinase II and effects of constitutively active CaM kinase II are consistent with a role for this enzyme in NMHC-IIA threonine phosphorylation, involvement of CaM kinase IV cannot be excluded. Since KN-93 is less effective against CaM kinase IV, a contribution from CaM kinase IV could explain the incomplete inhibition of NMHC-IIA threonine phosphorylation by KN-93.
There is increasing evidence that converging calcium/calmodulin-dependent pathways are important for secretion. Calmodulin-dependent activation of myosin light chain kinase and phosphorylation of myosin light chain is required for calciuminduced cortical F-actin disassembly (27) . CaM kinase inhibitors also inhibit insulin secretion in pancreatic cells (28) and gonadotropin-releasing hormone secretion from infundibular explants (29) , suggesting that there may be a more general role for CaM kinases in secretory processes. Threonine phosphorylation of NMHC-IIA is also found in pancreatic cells undergoing secretion (7, 30) . The effect of CaM kinase phosphorylation of Thr-1940 in NMHC-IIA on the interactions between actin and myosin (and possibly other cytoskeletal proteins) may give further insight into the secretory process. The ability of the CaM kinase inhibitor KN-93, but not the inactive analogue KN-92, to inhibit secretion in RBL-2H3 cells in response to carbachol lends further credence for a functional role for CaM kinase in mast cell secretion. The lack of effect of KN-93 on antigen-mediated secretion, and the absence of CaM kinase phosphorylation of NMHC-IIA in human cells, implies that NMHC-IIA threonine phosphorylation may have a facilitatory role rather than being essential for secretion. This may reflect redundancy in the IgE-mediated pathway, perhaps between PKC and CaM kinase-mediated NMHC-IIA phosphorylation. Alternatively, CaM kinase may be having additional upstream effects in the carbachol-mediated pathway which are responsible for the inhibition of carbachol-mediated secretion by KN-93.
The non-helical carboxyl-terminal region of the myosin rod modulates the assembly of myosin filaments (31) (32) (33) , and it has been suggested that phosphorylation of the NMHC carboxyl terminus affects filament formation in an isoform-specific manner; phosphorylation by either PKC or casein kinase inhibits assembly of NMHC-IIB isoforms, but not of NMHC-IIA (21). An alternative mechanism by which threonine phosphorylation of NMHC-IIA could affect filament assembly is through interactions with other proteins, and in particular with Mts 1. Mts 1 is a 9-kDa calcium-binding protein of the S100 family, which is up-regulated in cancer cells and highly motile cells (34) . Mts 1 binds to the non-helical region of NMHC and destabilizes filaments (35) . Binding occurs at residues 1909 -1937 of human platelet NMHC-IIA, and inhibits phosphorylation of Ser-1917 by PKC (36) . It will therefore be of interest to determine whether phosphorylation of NMHC-IIA at Thr-1940 has any effect on filament assembly or Mts 1 binding. Preliminary experiments have shown that Mts 1 also inhibits phosphorylation of NMHC-IIA by CaM kinase II in vitro. 3 Calcium-dependent threonine phosphorylation of NMHC-IIA has now been shown in a range of rodent cells, including PC12 rat pheochromacytoma cells and mouse NIE-115 neuroblastoma cells (6) , rat islets and rat RINm5F insulinoma cells (7) , in the mouse pancreatic cell line ␤TC6-F7 (30), and in mouse fibroblasts and rat RBL-2H3 mast cells. However, increasing intracellular calcium with ionomycin did not result in threonine phosphorylation of NMHC-IIA in HeLa cells or the Y79 retinoblastoma cell line, both of which are derived from humans. While the absence of some component of the signal transduction cascade leading to myosin phosphorylation cannot be excluded, a more likely explanation is a sequence difference between rodent and human NMHC-IIA, resulting in the absence of the phosphorylated threonine or targeting residues in human cells. The carboxyl terminus of mouse NMHC-IIA was phosphorylated in vitro by CaM kinase, while human NMHC-IIA carboxyl-terminal was not. Inspection of the sequences for rat and mouse NMHC-IIA distal to the coiled-coil region showed 2 conserved threonines which are absent in human NMHC-IIA; in particular, comparison of the conserved rat (17) and mouse 2 sequence surrounding Thr-1940 (Ile-ValArg-Lys-Gly-Thr-Gly) with the optimal CaM kinase consensus sequences for CaM kinase IV (Hyd-X-Arg-X-X-Ser/Thr) and CaM kinase IIa (Hyd-X-Arg-X-NB-Ser/Thr-Hyd) (37) show a good correspondence, while the sequence is less well conserved in human NMHC-IIA (Met-Ala-Arg-Lys-Gly-Ala-Gly) (22) .
This high degree of sequence conservation in rat and mouse made it a good candidate as the kinase target, which was confirmed with mutants of the NMHC-IIA fusion proteins. Mutation of Thr-1940 to Ala in mouse NMHC-IIA abrogated in vitro phosphorylation, while mutation of Ala-1940 to Thr in human NMHC-IIA restored phosphorylation by CaM kinase II. A peptide corresponding to rat NMHC-IIA residues 1933-1951 was phosphorylated in vitro by CaM kinase II on Thr-1940, indicating that the effects of mutation of residue 1940 on fusion protein phosphorylation were not due to indirect conformational changes. Co-expression experiments in HeLa cells showed that constitutively active CaM kinase II also phosphorylated mutant full-length NMHC-IIA containing Thr-1940, but not wild type NMHC-IIA. Taken together these data confirm that Thr-1940 of rodent NMHC-IIA is phosphorylated by CaM kinase II, and that the absence of this site in human NMHC-IIA explains the lack of threonine phosphorylation in stimulated human cells.
The absence of threonine phosphorylation in human cells is interesting, and may imply that they are able to rearrange their actomyosin cytoskeleton with only PKC-dependent serine phosphorylation of NMHC-II, in addition to serine phosphorylation of the nonmuscle myosin light chain. Conversely, human cells could have developed an alternative phosphoacceptor pathway, as has been demonstrated for the transcription factor C/EBP␤. The highly conserved threonine phosphoacceptor (Thr-217) in the transcription factor C/EBP␤ required for transforming growth factor ␣-mediated hepatocyte proliferation in mouse, is replaced by alanine in rat, while mouse/ human Ala-105 has been replaced by Ser-105 in rat (38) . The two phosphoacceptors have analogous functions, since mutation of mouse Thr-217 or rat Ser-105 with Ala blocks proliferation while replacement with Asp promotes proliferation in both cases. It will be of interest to determine by peptide mapping whether any additional phosphoacceptors have evolved in human NMHC-IIA to substitute for the phosphothreonine.
The activation of CaM kinase II that we have demonstrated also raises the possibility that CaM kinase could contribute to the changes in gene expression found following mast cell activation (39) . All three CaM kinases are found in the nucleus as well as the cytosol; for CaM kinase I and IV, nuclear localization is probably by diffusion through nuclear pores, while for CaM kinase II certain isoforms are targeted to the nucleus as a result of an alternatively spliced nuclear localization signal (40) . The nuclear CaM kinases can phosphorylate transcription factors such as cAMP-response element-binding protein, leading to changes in gene expression (40) .
In summary, stimulation of RBL-2H3 m1 cells with mediators which increase intracellular calcium leads to activation of CaM kinase II and phosphorylation of NMHC-IIA on Thr-1940. Inhibition of CaM kinase II decreases myosin phosphorylation in response to antigen and carbachol, and also inhibits secretion in response to carbachol. Threonine phosphorylation of NMHC-IIA thus appears to be obligatory for some but not all stimulants, and is species-dependent, which may indicate the existence of alternative pathways to achieve the appropriate functional response.
